Aerie Pharmaceuticals reported $228.19M in Loan Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Adamas Pharmaceuticals ADMS:US 124.48M 1.06M
Aerie Pharmaceuticals AERI:US $ 228.19M 6.17M
Amarin AMRN:US $ 0M 0M
Bluebird Bio BLUE:US $ 0M 0M
Coherus Biosciences CHRS:US $ 281.9M 5.18M
Endo International Ordinary Shares ENDP:US $ 8070.77M 3.67M
Flexion Therapeutics FLXN:US $ 250.5M 30.48M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Horizon Pharma HZNP:US $ 2557.86M 2.58M
Insmed INSM:US $ 571.41M 8.55M
JAZZ PHA JAZZ:US $ 6253.65M 241.68M
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NOVN:VX SF 24715M 1776M
Pacira Pharmaceuticals PCRX:US $ 326.15M 4.44M
Regeneron Pharmaceuticals REGN:US $ 1979.6M 0.4M
Revance Therapeutics RVNC:US $ 280.32M 0.32M
Supernus Pharmaceuticals SUPN:US $ 374.79M 4.4M
Teva Pharmaceutical Industries TEVA:US $ 21037M 565M
Valeant Pharmaceuticals VRX:CN $ 22358M 1081M
Zoetis ZTS:US $ 6592M 0M
Zogenix ZGNX:US $ 155.87M 2.24M